Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-1994 | 03-1994 | 12-1993 | 09-1993 | 06-1993 | |
Sales | 1,923,300 | 1,982,900 | 1,989,200 | 1,872,500 | 1,748,700 |
Cost of Goods | 464,100 | 432,200 | 475,100 | 436,400 | 437,100 |
Gross Profit | 1,459,200 | 1,550,700 | 1,514,100 | 1,436,100 | 1,311,600 |
Operating Expenses | 1,062,100 | 985,400 | 1,107,800 | 988,300 | 988,800 |
Operating Income | 397,200 | 565,500 | 406,400 | 448,200 | 322,900 |
Interest Expense | 29,600 | 34,200 | 25,200 | 29,600 | 26,800 |
Other Income | 2,200 | -1,300 | 10,300 | -746,900 | 47,800 |
Pre-tax Income | 369,800 | 530,000 | 391,500 | -328,300 | 343,900 |
Income Tax | 110,900 | 159,000 | 101,700 | -115,500 | 89,600 |
Net Income Continuous | 257,200 | 370,700 | 288,900 | -214,200 | 253,800 |
Net Income | $257,200 | $370,700 | $288,900 | $-214,200 | $253,800 |
EPS Basic Total Ops | 0.07 | 0.10 | 0.08 | -0.05 | 0.07 |
EPS Basic Continuous Ops | 0.07 | 0.10 | 0.08 | -0.05 | 0.07 |
EPS Diluted Total Ops | 0.07 | 0.10 | 0.08 | -0.05 | 0.07 |
EPS Diluted Continuous Ops | 0.07 | 0.10 | 0.08 | -0.05 | 0.07 |
EBITDA(a) | $397,200 | $565,500 | $406,400 | $448,200 | $322,900 |